Phase IV, 8-Week, Multicenter, Randomized, Active Treatment–Controlled, Parallel Group, Efficacy, and Tolerability Study of High-Dose Candesartan Cilexetil Combined With Hydrochlorothiazide in Korean Adults With Stage II Hypertension-Reference-Cited by-同舟云学术

Phase IV, 8-Week, Multicenter, Randomized, Active Treatment–Controlled, Parallel Group, Efficacy, and Tolerability Study of High-Dose Candesartan Cilexetil Combined With Hydrochlorothiazide in Korean Adults With Stage II Hypertension

Published:2011-08 Issue:8 Volume:33 Page:1043-1056
ISSN:0149-2918
Container-title:Clinical Therapeutics
language:en
Short-container-title:Clinical Therapeutics

Author:

Lee Hae-Young,Hong Bum-Kee,Chung Wook Jin,Lee Byoung Kwon,Lee Seung Hwan,Jeon Dong Woon,Ahn Young Keun,Kim Dooil,Park Chang Kyu,Kim Sang-Hyun,Jung Hae Ok,Kim Byung-Ok,Choi Donghoon

Funder

AstraZeneca

Publisher

Elsevier BV

Subject

Pharmacology (medical),Pharmacology

Reference13 articles.

1. 2007 guidelines for the management of arterial hypertension: the task force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC);Mancia;J Hypertens,2007

2. The seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: The JNC 7 report;Chobanian;JAMA,2003

3. Combination therapy with diuretics: an evolution of understanding;Neutel;Am J Med,1996

4. Improving antihypertensive efficacy while maintaining placebo-like tolerability;Sever;Blood Press Suppl,2000

5. Supramaximal dose of candesartan in proteinuric renal disease;Burgess;J Am Soc Nephrol,2009

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Angiotensin receptor blockers: Focus on cardiac and renal injury;Trends in Cardiovascular Medicine;2016-04

2. A Randomized, Multicenter, Double-blind, Placebo-controlled, 3 × 3 Factorial Design, Phase II Study to Evaluate the Efficacy and Safety of the Combination of Fimasartan/Amlodipine in Patients With Essential Hypertension;Clinical Therapeutics;2015-11

3. The benefits of candesartan usage in the treatment of arterial hypertension;Systemic Hypertension;2014-06-15

4. Improved simultaneous quantitation of candesartan and hydrochlorthiazide in human plasma by UPLC–MS/MS and its application in bioequivalence studies;Journal of Pharmaceutical Analysis;2014-04

5. Candesartan in treating hypertension;Systemic Hypertension;2014-03-15